本文關鍵詞： 腸出血性大腸桿菌O157:H7 ler基因 志賀毒素 突變 疫苗　出處：《吉林大學》2007年博士論文　論文類型：學位論文

【摘要】： 本研究首先建立腸出血性大腸桿菌O157:H7感染的動物模型,利用絲裂霉素對小鼠進行腹腔注射預處理,并通過灌胃接種和腹腔注射兩種途徑,建立了O157:H7感染的動物模型。然后對EHEC O157:H7 ler/stx基因缺失突變菌株的原噬菌體及其原始整合位點進行分析。通過對Stx A亞基毒性活性區(qū)和跨膜區(qū)的定點突變,消除或降低Stx的細胞毒性,并將Stx的無毒性或弱毒性突變體導入O157:H7 ler/stx基因缺失突變菌株,構建O157重組弱毒疫苗菌株。利用小鼠模型和vero細胞對O157重組弱毒疫苗菌株的vero細胞毒性、對小鼠的致病性、重組菌株的穩(wěn)定性,以及被動免疫和主動免疫保護性進行了研究。 結果表明,O157重組弱毒疫苗菌株具有良好的穩(wěn)定性,對vero細胞的毒性作用降低了約104倍,喪失了對小鼠模型的致病性,能有效縮短小鼠感染O157:H7強毒株后的排毒時間(免疫組小鼠第6天后糞便內(nèi)即檢測不到強毒株,而未免疫對照組第13天仍可檢測到)。用疫苗菌株對母鼠免疫,免疫母鼠所生的乳鼠通過吸吮母乳,能夠獲得良好的被動免疫保護作用(F25和F105的免疫保護率分別為75.2%和83.0%);通過腹腔注射的途徑對小鼠進行免疫和攻毒,結果也表明O157重組弱毒疫苗菌株對小鼠具有良好的免疫保護作用(F25和F105的免疫保護作用分別為11/20和14/20)。
[Abstract]:In this study, the animal model of enterohemorrhagic Escherichia coli O157: H7 infection was established. The mice were pretreated by intraperitoneal injection of mitomycin, and were injected intraperitoneally and intraperitoneally. The animal model of O157: H7 infection was established. The phage and its original integration site of EHEC O157: H7 ler/stx gene deletion mutant strain were analyzed. The site-directed mutations of the toxic active region and transmembrane region of Stx A subunit were carried out. The cytotoxicity of Stx was eliminated or reduced, and the non-toxic or weakly toxic mutants of Stx were introduced into O157: H7 ler/stx gene deletion mutant. A recombinant attenuated vaccine strain O157 was constructed. The pathogenicity, stability, passive immunity and active immune protection of O157 recombinant attenuated vaccine strain were studied by using mouse model and vero cells to study the vero cytotoxicity of O157 recombinant attenuated vaccine strain. The results showed that the recombinant attenuated vaccine strain of YO157 had good stability, the toxicity to vero cells was reduced by about 104-fold, and the pathogenicity of the strain was lost to the mouse model. It can effectively shorten the detoxification time of mice infected with O157: H7 virulent strain (the mice in the immunized group could not detect the virulent strain in feces after 6 days, while the mice in the unimmunized control group could still be detected on the 13th day after inoculation with the vaccine strain. The immune protection rates of F25 and F105 were 75.2% and 83.0 by sucking breast milk, respectively, and the mice were immunized and poisoned by intraperitoneal injection. The results also showed that the recombinant attenuated strain O157 had a good protective effect on mice. The protective effects of F25 and F105 on mice were 11/20 and 14 / 20 respectively.
【學位授予單位】：吉林大學
【學位級別】：博士
【學位授予年份】：2007
【分類號】：R392

【參考文獻】

相關期刊論文 前3條

1 王真行;產(chǎn)腸毒素性大腸桿菌(ETEC)菌苗和腸出血性大腸桿菌(EHEC)菌苗研制現(xiàn)狀(下)[J];國外醫(yī)學.預防.診斷.治療用生物制品分冊;1999年06期

2 劉軍;孫洋;馮書章;;出血性大腸桿菌O157基因缺失疫苗株的構建及其免疫[J];生物工程學報;2007年02期

3 陳亢川,郭維植,程法稷,林成水,林杰,董新平;福建省O157大腸桿菌調(diào)查[J];中華預防醫(yī)學雜志;2000年03期

，

本文編號：1498572